Access cutting-edge plaque psoriasis treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access plaque psoriasis specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related plaque psoriasis treatment provided free
The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.
Sponsor: Eli Lilly and Company
Check if you qualify for this plaque psoriasis clinical trial in Phoenix, AZ
If you're searching for plaque psoriasis treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.